CAR T Cells in Cancer Gene Therapy

CAR T-cell therapy is a groundbreaking approach in cancer gene therapy that harnesses a patient’s immune cells to target and destroy cancer cells. In this technique, T-cells are genetically modified to express chimeric antigen receptors (CARs) that specifically recognize cancer cells. Once...

• The speaker introduces their diagnostics portfolio, highlighting liquid biopsy as the flagship product, alongside therapeutic efforts focused on immuno-oncology, particularly cell-based immunotherapies like CAR-T cells. Other therapies mentioned include CAR-NK cells, macrophages, T-regs, and tumor-infiltrating lymphocytes, but the main focus is on CAR-T cells due to their clinical approval and market presence.